[go: up one dir, main page]

MX2019010563A - Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar. - Google Patents

Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar.

Info

Publication number
MX2019010563A
MX2019010563A MX2019010563A MX2019010563A MX2019010563A MX 2019010563 A MX2019010563 A MX 2019010563A MX 2019010563 A MX2019010563 A MX 2019010563A MX 2019010563 A MX2019010563 A MX 2019010563A MX 2019010563 A MX2019010563 A MX 2019010563A
Authority
MX
Mexico
Prior art keywords
probes
unbounded
fluorescent
development
bilirubin
Prior art date
Application number
MX2019010563A
Other languages
English (en)
Other versions
MX380526B (es
Inventor
Zhu Baolong
Marc Kleinfeld Alan
Henry Huber Andrew
Kwan Thomas
Patrick Kampf James
Original Assignee
Marc Kleinfeld Alan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marc Kleinfeld Alan filed Critical Marc Kleinfeld Alan
Publication of MX2019010563A publication Critical patent/MX2019010563A/es
Publication of MX380526B publication Critical patent/MX380526B/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/728Bilirubin; including biliverdin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • Y10T436/146666Bile pigment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Se describe la identificación y uso de proteínas marcadas fluorescentemente y que sufren un cambio en el índice de fluorescencia después del enlace a bilirrubina. Se revelan sondas que son marcadas en un residuo de cisteína o lisina y también sondas marcadas tanto en cisteína como en lisina con dos fluoróforos diferentes. Estas sondas son útiles para la determinación de niveles de bilirrubina sin enlazar en una muestra del fluido.
MX2019010563A 2011-08-26 2012-08-24 Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar MX380526B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161527849P 2011-08-26 2011-08-26
PCT/US2012/052395 WO2013032953A2 (en) 2011-08-26 2012-08-24 Development and use of fluorescent probes of unbound bilirubin

Publications (2)

Publication Number Publication Date
MX2019010563A true MX2019010563A (es) 2019-10-24
MX380526B MX380526B (es) 2025-03-12

Family

ID=47757131

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014002051A MX347754B (es) 2011-08-26 2012-08-24 Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar.
MX2019010563A MX380526B (es) 2011-08-26 2012-08-24 Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2014002051A MX347754B (es) 2011-08-26 2012-08-24 Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar.

Country Status (12)

Country Link
US (3) US9529003B2 (es)
EP (2) EP2748615B1 (es)
JP (3) JP6104913B2 (es)
CN (2) CN104220877B (es)
AU (3) AU2012300319B8 (es)
CA (1) CA2846106C (es)
CY (1) CY1122022T1 (es)
DK (1) DK2748615T3 (es)
ES (1) ES2733974T3 (es)
MX (2) MX347754B (es)
PT (1) PT2748615T (es)
WO (1) WO2013032953A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2920204B1 (en) * 2012-11-16 2019-09-18 IBA GmbH Streptavidin muteins and methods of using them
EP2963115B1 (en) * 2013-02-28 2020-04-01 Riken Novel polypeptide exhibiting fluorescent properties and use thereof
WO2015084894A1 (en) 2013-12-03 2015-06-11 Alan Kleinfeld Determination of the unbound free fatty acid profiles in biological and industrial specimens
US20160146838A1 (en) * 2014-11-20 2016-05-26 Jean Ronald Brisard System and method for ebola detection
CN104819981B (zh) * 2015-05-16 2017-11-21 山东耀华医疗器械股份有限公司 一种尿液成分测量仪
US11078254B2 (en) * 2017-04-11 2021-08-03 National Institute Of Advanced Industrial Science And Technology Method for immobilizing lectin
JP7166429B2 (ja) * 2018-04-03 2022-11-07 ネオメトリックス ディーエックス, インコーポレイテッド ビリルビンのin vivo毒性レベルを評価し、ビリルビン神経毒性の増大したリスクを診断するための、方法およびデバイス
CN111334079A (zh) * 2018-12-18 2020-06-26 中国科学院大连化学物理研究所 一种全光谱高亮度、高稳定性荧光染料及其合成和应用
US20230053493A1 (en) * 2019-08-30 2023-02-23 Alan Marc Kleinfeld One step methods, kits, and systems for the measurement of concentrations of unbound bilirubin in biological fluids
CN111239094B (zh) * 2020-03-13 2022-08-26 河南中医药大学 一种碱性磷酸酶的灵敏检测方法
CN113238041B (zh) * 2021-01-13 2024-01-16 军事科学院军事医学研究院环境医学与作业医学研究所 一种基于β-环糊精修饰的免疫生物条形码增敏探针以及快速检测阿特拉津的方法
US11908583B2 (en) * 2022-05-02 2024-02-20 Kpn Innovations, Llc. Apparatus and method for determining toxic load quantifiers
WO2025065355A1 (zh) * 2023-09-27 2025-04-03 京东方科技集团股份有限公司 针对亨廷顿舞蹈症的早期诊断的多肽探针和试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470714A (en) 1989-12-12 1995-11-28 Lidak Pharmaceuticals One-step free fatty acid determination method
US6444432B1 (en) 1997-06-13 2002-09-03 Alan M. Kleinfeld Method of detection of cardiac ischemia using fatty acid binding protein
JP4719403B2 (ja) 2000-08-15 2011-07-06 ディサーナ リミテッド 機能的タンパク質アレイ
EP2821793B1 (en) * 2004-03-22 2017-04-19 FFA Sciences, LLP Development and use of fluorescent probes of unbound analytes
US20060257938A1 (en) * 2005-05-10 2006-11-16 Kleinfeld Alan M Method of screening for drugs that block ligand binding to a lipid binding protein
WO2008060841A2 (en) * 2006-10-27 2008-05-22 Ffa Sciences, Llc Use of probes for unbound metabolites
US9134317B2 (en) 2008-01-18 2015-09-15 Alan Kleinfeld Development and use of cysteine-labeled fluorescent probes of unbound analytes

Also Published As

Publication number Publication date
CY1122022T1 (el) 2020-10-14
MX380526B (es) 2025-03-12
JP6694403B2 (ja) 2020-05-13
PT2748615T (pt) 2019-07-22
EP3598139A1 (en) 2020-01-22
WO2013032953A3 (en) 2013-08-08
US10295551B2 (en) 2019-05-21
MX2014002051A (es) 2014-09-12
AU2012300319B8 (en) 2017-07-27
AU2017208236A1 (en) 2017-08-10
DK2748615T3 (da) 2019-07-29
AU2012300319A1 (en) 2014-02-27
EP2748615A2 (en) 2014-07-02
CN104220877A (zh) 2014-12-17
AU2017208236B2 (en) 2019-04-18
AU2019206014A1 (en) 2019-09-26
JP2019146569A (ja) 2019-09-05
US20190212346A1 (en) 2019-07-11
US9529003B2 (en) 2016-12-27
EP2748615B1 (en) 2019-05-01
US11029320B2 (en) 2021-06-08
CN108051584B (zh) 2021-02-12
MX347754B (es) 2017-05-11
JP2017104128A (ja) 2017-06-15
AU2012300319A8 (en) 2017-07-27
ES2733974T3 (es) 2019-12-03
US20170097366A1 (en) 2017-04-06
JP6847141B2 (ja) 2021-03-24
AU2012300319A2 (en) 2015-06-04
AU2019206014B2 (en) 2021-10-07
CN108051584A (zh) 2018-05-18
AU2012300319B2 (en) 2017-07-13
CA2846106A1 (en) 2013-03-07
WO2013032953A2 (en) 2013-03-07
EP2748615A4 (en) 2015-07-08
JP2014526055A (ja) 2014-10-02
JP6104913B2 (ja) 2017-03-29
CN104220877B (zh) 2018-05-15
WO2013032953A8 (en) 2014-04-03
US20150044692A1 (en) 2015-02-12
CA2846106C (en) 2020-09-01

Similar Documents

Publication Publication Date Title
MX2019010563A (es) Desarrollo y uso de sondas fluorescentes de bilirrubina sin enlazar.
ES2506116T3 (es) Nuevo biomarcador para diagnóstico, predicción y/o pronóstico de septicemia y usos del mismo
MX367366B (es) Composiciones y metodos para diagnosticar tumores de tiroides.
MX356986B (es) Metodo para detectar aductos de nucleosomas.
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
MX2015013219A (es) Imagenologia por fluorescencia de enfermedades inflamatorias.
BR112015022766A2 (pt) sistemas de espectroscopia de fluorescência induzida por laser resolvida no tempo e método de uso do mesmo
CR20120581A (es) Proteínas de unión a il-1
BRPI1013688A8 (pt) Proteínas de ligação de il-17.
ES2570632T3 (es) Procedimiento de determinación del inhibidor de elastasa de leucocito in vitro del cáncer colorrectal
MX2012004619A (es) Ensayos regulados mediante proximidad para detectar proteinas de fusion oncogenicas.
PE20160657A1 (es) Composiciones y metodos para identificar un riesgo de cancer en un sujeto
CL2011002003A1 (es) Anticuerpo humanizado o fragmentos de este, que se unen al receptor del factor de crecimiento epidérmico (egfr) en una expresión aberrante o al egfr truncado ?2-7; célula huésped; composición farmacéutica que lo comprende; y su uso para tratar tratar cáncer.
MX360236B (es) Uso de marcadores en el diagnostico y tratamiento de cancer de prostata.
GB201305223D0 (en) Reflection detection type measurement apparatus for skin autofluorescence
BR112016010106A2 (pt) ensaios para igfbp7 com melhor desempenho em amostras biológicas
MX2013013832A (es) Proteínas de unión receptoras fc.
DOP2014000111A (es) Proteínas que pueden unirse a la il-1
MX353954B (es) Aptameros y metodos de diagnostico para detectar el receptor del factor de crecimiento epidermal (egf).
MX2017014196A (es) Deteccion de factores de virulencia microbiana bucal.
CL2011002509A1 (es) Cartucho para la verificacion y el analisis cuantitativo de analito en un liquido de muestra que incorpora una camara de reactivos, una camara de deteccion; procedimiento para analisis cuantitativo de analito; y uso del cartucho.
BR112015027553A2 (pt) cartucho de imageamento, pipeta e método de uso para microscopia de esfregaço de expectoração direta
MX363845B (es) Anticuerpo anti-caix para usarse en el tratamiento de carcinoma de células claras renales.
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento